4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-054346
President and Chief Executive acquired 37,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2023-11-01 | Grant or award | +37,500 | 427,171 | D |
Loading xslF345X05/doc4.xml…